Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CARDAMOM: Eplerenone vs Chlorthalidone in Women with Prior Pregnancy-Induced Hypertension
NCT07238400Phase 2Recruiting
- Sponsor
- Massachusetts General Hospital
- Start
- Mar 2026
- Primary completion
- Mar 2029
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of eplerenone in hypertension (HTN), sponsored by Massachusetts General Hospital. Started Mar 2026; status: recruiting.
02
Drugs
eplerenone
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on NCT07238400.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07238400.